EditorialKommentar
Minimal residual disease in CLL: when does it really matter?
Blood · 11.06.2026 · 147 (24) · 2852-2854
DOI: 10.1182/blood.2026033673 ↗Kurz gefasst
Editorial in der Zeitschrift Blood, erschienen am 11.06.2026. Verfasst von Antonio Cuneo und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Ferrara. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- University of Ferrara.
- Università Vita-Salute San Raffaele.
- IRCCS Ospedale San Raffaele.
ORCID-Profile: Antonio Cuneo, Paolo Ghia
Zitieren
APA
Cuneo, A., & Ghia, P. (2026). Minimal residual disease in CLL: when does it really matter?. Blood, 147(24), 2852-2854. https://doi.org/10.1182/blood.2026033673
Vancouver
Cuneo A, Ghia P. Minimal residual disease in CLL: when does it really matter?. Blood. 2026;147(24):2852-2854. doi:10.1182/blood.2026033673
BibTeX
@article{Cuneo2026,
author = {Cuneo, Antonio and Ghia, Paolo},
title = {Minimal residual disease in CLL: when does it really matter?},
journal = {Blood},
year = {2026},
volume = {147},
number = {24},
pages = {2852--2854},
doi = {10.1182/blood.2026033673}
}
EUVIMED